fluoxetine has been researched along with Sensation Disorders in 5 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Sensation Disorders: Disorders of the special senses (i.e., VISION; HEARING; TASTE; and SMELL) or somatosensory system (i.e., afferent components of the PERIPHERAL NERVOUS SYSTEM).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blatteau, JE | 1 |
de Maistre, S | 1 |
Lambrechts, K | 1 |
Abraini, J | 1 |
Risso, JJ | 1 |
Vallée, N | 1 |
King, VL | 1 |
Horowitz, IR | 1 |
Zajecka, J | 1 |
Tracy, KA | 1 |
Mitchell, S | 1 |
Ellison, JM | 1 |
DeLuca, P | 1 |
Michael, A | 1 |
Mayer, C | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19)[NCT04570449] | Early Phase 1 | 0 participants (Actual) | Interventional | 2020-11-30 | Withdrawn (stopped due to Study timeline is not feasible) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for fluoxetine and Sensation Disorders
Article | Year |
---|---|
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Femal | 1997 |
4 other studies available for fluoxetine and Sensation Disorders
Article | Year |
---|---|
Fluoxetine stimulates anti-inflammatory IL-10 cytokine production and attenuates sensory deficits in a rat model of decompression sickness.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Decompression Sickness; Fluoxet | 2015 |
Vaginal anesthesia associated with fluoxetine use.
Topics: Adult; Depressive Disorder; Female; Fluoxetine; Humans; Sensation Disorders; Vaginal Diseases; Vulva | 1993 |
Fluoxetine-induced genital anesthesia relieved by Ginkgo biloba extract.
Topics: Adult; Female; Flavonoids; Fluoxetine; Genitalia, Female; Ginkgo biloba; Humans; Hypesthesia; Plant | 1998 |
Fluoxetine-induced anaesthesia of vagina and nipples.
Topics: Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Middle Aged; Nipples; Sensatio | 2000 |